SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, Ayal Schaffer, Serge Beaulieu, Martin Alda, Claire O’Donovan, Glenda MacQueen, Roger S McIntyre, Verinder Sharma, Arun Ravindran, L Trevor Young, Roumen Milev, David J Bond, Benicio N Frey, Benjamin I Goldstein, Beny Lafer, Boris Birmaher, Kyooseob Ha, Willem A Nolen, Michael Berk, Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013, Bipolar Disorders, 2013, 15, 1
  2. 2
    Sergio Filippis, Ilaria Cuomo, Luana Lionetto, Delfina Janiri, Maurizio Simmaco, Matteo Caloro, Simone Persis, Gioia Piazzi, Alessio Simonetti, C Ludovica Telesforo, Antonio Sciarretta, Federica Caccia, Giovanna Gentile, Georgios D. Kotzalidis, Paolo Girardi, Intramuscular Aripiprazole in the Acute Management of Psychomotor Agitation, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013, 33, 6
  3. 3
    Esther W. Chan, David C.M. Kong, Jonathan C. Knott, David J. Castle, Ethical issues in researching interventions for behavioral disturbance in psychotic disorders, Asia-Pacific Psychiatry, 2012, 4, 2
  4. 4
    Alkomiet Hasan, Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, Birte Glenthoj, Wagner F. Gattaz, Florence Thibaut, Hans-Jürgen Möller, World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance, World Journal of Biological Psychiatry, 2012, 13, 5, 318

    CrossRef

  5. 5
    M. Passamar, O. Tellier, B. Vilamot, L’agitation psychomotrice, la sédation médicamenteuse et l’urgence psychiatrique chez le patient psychotique, L'Encéphale, 2011, 37, 6, 448

    CrossRef

  6. 6
    Scott L. Zeller, Robert W. Rhoades, Systematic reviews of assessment measures and pharmacologic treatments for agitation, Clinical Therapeutics, 2010, 32, 3, 403

    CrossRef

  7. 7
    Alfonso Carvajal, Luis H. Martín Arias, Natalia Jimeno, Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions, 2010,

    CrossRef

  8. You have free access to this content8
    Lakshmi N Yatham, Sidney H Kennedy, Ayal Schaffer, Sagar V Parikh, Serge Beaulieu, Claire O'Donovan, Glenda MacQueen, Roger S McIntyre, Verinder Sharma, Arun Ravindran, L Trevor Young, Allan H Young, Martin Alda, Roumen Milev, Eduard Vieta, Joseph R Calabrese, Michael Berk, Kyooseob Ha, Flávio Kapczinski, Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009, Bipolar Disorders, 2009, 11, 3
  9. 9
    R. Chandrasena, D. Dvořáková, S. I. Lee, N. Loza, S. N. Mosolov, P. Osváth, P. Pregelj, R. J. Walton, J. Karagianis, T. Treuer, Intramuscular olanzapine vs. intramuscular short-acting antipsychotics: safety, tolerability and the switch to oral antipsychotic medication in patients with schizophrenia or acute mania, International Journal of Clinical Practice, 2009, 63, 8
  10. 10
    T. Bougerol, Les états délirants aigus, L'Encéphale, 2009, 35, S146

    CrossRef

  11. 11
    Jodi L. Miller, J. Wesson Ashford, Sanford M. Archer, Anita C. Rudy, Daniel P. Wermeling, Comparison of Intranasal Administration of Haloperidol with Intravenous and Intramuscular Administration: A Pilot Pharmacokinetic Study, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2008, 28, 7
  12. 12
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2008, 17, 3
  13. 13
    G. Rohmer, A. Gassiot, Place des antipsychotiques atypiques dans le traitement des troubles de l’humeur, L'Encéphale, 2008, 34, S213

    CrossRef